Business Description
Sorrento Therapeutics Inc
NAICS : 325414
SIC : 8731
ISIN : US83587F2020
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.39 | |||||
Equity-to-Asset | -0.45 | |||||
Debt-to-Equity | -1.01 | |||||
Debt-to-EBITDA | -0.39 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -10.87 | |||||
Beneish M-Score | -3.37 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -12.5 | |||||
3-Year EBITDA Growth Rate | 16.7 | |||||
3-Year EPS without NRI Growth Rate | 12.7 | |||||
3-Year FCF Growth Rate | 17.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.95 | |||||
9-Day RSI | 42.17 | |||||
14-Day RSI | 44.6 | |||||
6-1 Month Momentum % | -51.26 | |||||
12-1 Month Momentum % | -83.5 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.5 | |||||
Quick Ratio | 0.47 | |||||
Cash Ratio | 0.3 | |||||
Days Inventory | 142.59 | |||||
Days Sales Outstanding | 150.64 | |||||
Days Payable | 295.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -45.3 | |||||
Shareholder Yield % | -1222.63 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 44.56 | |||||
Operating Margin % | -553.17 | |||||
Net Margin % | -852.8 | |||||
FCF Margin % | -378.42 | |||||
ROA % | -103.91 | |||||
ROIC % | -78.82 | |||||
ROC (Joel Greenblatt) % | -424.7 | |||||
ROCE % | -178.27 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.11 | |||||
EV-to-EBIT | -0.25 | |||||
EV-to-Forward-EBIT | -2.7 | |||||
EV-to-EBITDA | -0.25 | |||||
EV-to-Revenue | 2.1 | |||||
EV-to-Forward-Revenue | 3.22 | |||||
EV-to-FCF | -0.56 | |||||
Earnings Yield (Greenblatt) % | -400 | |||||
FCF Yield % | -3267.66 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SRNE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Sorrento Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 64.27 | ||
EPS (TTM) ($) | -1.12 | ||
Beta | 1.81 | ||
Volatility % | 250.51 | ||
14-Day RSI | 44.6 | ||
14-Day ATR ($) | 0.012191 | ||
20-Day SMA ($) | 0.018385 | ||
12-1 Month Momentum % | -83.5 | ||
52-Week Range ($) | 0.0001 - 0.419 | ||
Shares Outstanding (Mil) | 551.28 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Sorrento Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Sorrento Therapeutics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Sorrento Therapeutics Inc Frequently Asked Questions
What is Sorrento Therapeutics Inc(SRNE)'s stock price today?
When is next earnings date of Sorrento Therapeutics Inc(SRNE)?
Does Sorrento Therapeutics Inc(SRNE) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |